| Literature DB >> 28667269 |
Yan Zhao1, Yue Zhang2, Xiaoman Liu1, Hui Kong2, Yongzhi Wang2, Gaofeng Qin1, Peng Cao1, Xingxing Song1, Xin Yan2, Qingguo Wang1, Huihua Qu3.
Abstract
In this study, the properties of egg yolk oil (Entities:
Mesh:
Substances:
Year: 2017 PMID: 28667269 PMCID: PMC5493685 DOI: 10.1038/s41598-017-04073-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Preparation procedure of egg yolk oil carbon dots (EYO CDs).
Figure 2(A) Transmission electron microscopy (TEM) image of egg yolk oil carbon quantum dots (EYO CDs). (magnification 145,000x), the accelerating voltage was 100 kV. (B) Histograms of particle size distribution of EYO CDs. (magnification 880,000x), the accelerating voltage was 200 kV. (C and D) High-resolution TEM (HRTEM) images of individual EYO CDs. (E) The line profiles of the corresponding HRTEM images of EYO CDs. The lattice fringe (d = 0.267 nm) induced from the inplane diffraction of graphene.
Figure 3Characterization of egg yolk oil carbon quantum dots (EYO CDs). (A) UV absorption spectra of the EYO CDs at a concentration of 25 μg/mL. (B) Emission spectra of EYO CDs excited at 360 nm. (C) Fluorescence spectra of EYO CDs with different excitation wavelengths. (D) Excitation spectra of EYO CDs with different emission wavelengths. (E) Elemental analysis of EYO CDs. (F) Fourier transform infrared (FTIR) spectrum of the EYO CDs (32 scans at 2 cm−1 resolution in the scanning range of 400–4000 cm−1).
Figure 4(A) Haemostatic effect of egg yolk oil carbon quantum dots (EYO CDs) in mouse tail transection model. (B) Haemostatic effect of EYO CDs evaluated by liver laceration bleeding model. The male Kunming mice were divided into normal group (treated with saline, NS), positive drug group (treated with haemocoagulase, HC), high-dose EYO CDs, medium-dose EYO CDs, and low-dose EYO CDs. (n = 9 per group).
Figure 5Haemostatic mechanism of egg yolk oil carbon quantum dots (EYO CDs) in mouse tail transection. The male Kunming mice were divided into normal group (treated with saline, NS), positive drug group (treated with haemocoagulase, HC), high-dose EYO CDs, medium-dose EYO CDs, and low-dose EYO CDs. (n = 9 per group). (A) The value of prothrombin time (PT) (B). The value of activated partial thromboplastin time (APTT) (C). The value of fibrinogen (FIB). (D)The value of thrombin time (TT) (E). The value of blood platelets (PLT).